AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD

The recent development of silver nanoparticles (AgNPs) has sparked increased interest in biomedical and pharmaceutical applications, leading to the possibility of human exposure. The liver is the primary target organ in the metabolism and transport of nanoparticles. Non-alcoholic fatty liver disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Ling, Li, Minyan, Lin, Xiaojun, Li, Yan, Song, Huidong, Chen, Hanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169095/
https://www.ncbi.nlm.nih.gov/pubmed/35677306
http://dx.doi.org/10.3389/fbioe.2022.912178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169095/
https://www.ncbi.nlm.nih.gov/pubmed/35677306
http://dx.doi.org/10.3389/fbioe.2022.912178

Ejemplares similares